# FDA recall D-0262-2024

> **BE PHARMACEUTICALS AG** · Class II · drug recall initiated 2024-01-10.

## Product

Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.

## Reason for recall

Lack of Sterility Assurance: Aseptic process simulation failure.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0262-2024
- **Recalling firm:** BE PHARMACEUTICALS AG
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-01-10
- **Report date:** 2024-01-31
- **Termination date:** 2025-06-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Zug, N/A, Switzerland

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0262-2024

## Citation

> AI Analytics. FDA recall D-0262-2024. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-0262-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*